Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients
Launched by IRCCS SAN RAFFAELE · Apr 26, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the quality of life and health outcomes for men diagnosed with testicular cancer. Researchers aim to gather important information about the challenges faced by these patients and create a comprehensive database to enhance the knowledge of this disease. The ultimate goal is to improve how testicular cancer is diagnosed and treated.
To participate in this study, men must be over 18 years old and have a suspected or confirmed case of testicular cancer that requires surgery. Participants should also be able to understand the study and give their consent to join. During the trial, participants can expect to share their experiences and symptoms related to their condition, which will help researchers develop better care strategies. This study is currently recruiting participants, so if you or someone you know fits the criteria, it could be a valuable opportunity to contribute to important cancer research.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery
- • patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes
- • subjects \> 18 years old
- • subjects with at least elementary education
- • signature of informed consent
- Exclusion Criteria:
- • subjects \< 18 years
- • presence of mental or physical disability that may prevent the patient from satisfying the requirements of the protocol
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Lombardy, Italy
Patients applied
Trial Officials
Andrea Salonia, MD
Principal Investigator
IRCCS Ospedale San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported